Industry · AI News ·
Novo Nordisk and AWS bring agentic AI into drug discovery
Novo Nordisk is expanding its use of AWS AI tools in drug discovery, including agents for target identification, therapy design and research workflows. AWS will serve as the company’s preferred cloud provider and strategic AI partner, with a co-innovation hub established in London.